Rilpivirine and cabotegravir trough concentrations in people with HIV on long-term treatment with long-acting injectable antiretrovirals

MV Cossu, D Cattaneo, D Moschese… - Journal of …, 2024‏ - academic.oup.com
Objective Large inter-individual variability in the pharmacokinetics of rilpivirine and
cabotegravir has been reported in the first weeks after starting long-acting injectable (LAI) …

Structure-Guided Antiviral Peptides Identification Targeting the HIV-1 Integrase

MS Hossain, MS Alom, MS Kader… - ACS Physical …, 2024‏ - ACS Publications
HIV-1 integrase (IN), a major protein in the HIV life cycle responsible for integrating viral
cDNA into the host DNA, represents a promising drug target. Small peptides have emerged …

Transitions in treatment: A systematic review and meta‐aggregation of preferences and barriers in switching from oral to long‐acting injectable antiretroviral therapy …

T Hu, S Yang, J Yu, Z Yang, Y **, Z Zhu - HIV medicine‏ - Wiley Online Library
Introduction Antiretroviral treatment (ART) has significantly enhanced health outcomes for
people living with HIV (PLWH). With the evolution of treatment options, there is an increasing …